Peter Kjaer serves as Executive at BIOSANTE PHARMACEUTICALS INC, where they oversee executive responsibilities. Since joining the company, Peter Kjaer has executed 5 insider transactions totaling $54.5K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jan 8, 2008 involved purchasing 3,000 shares valued at $10.9K.
Peter Kjaer currently holds 29,725 shares of BIOSANTE PHARMACEUTICALS INC (BPAX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Peter Kjaer has been a net buyer of BPAX stock. They have purchased $54.5K and sold $0 worth of shares.
Peter Kjaer's most recent insider trade was on Jan 8, 2008, when they purchased 3,000 shares at $3.63 per share.
Get notified when new Form 4 filings are submitted
| $3.70 |
| Discretionary |
| Jan 7, 2008 | BPAX | $11.8K | Purchase | 3,300 | $3.59 | Discretionary |
| Jan 7, 2008 | BPAX | $7.2K | Purchase | 2,000 | $3.60 | Discretionary |
| Jan 7, 2008 | BPAX | $7.2K | Purchase | 2,000 | $3.59 | Discretionary |